TransMedics, headquartered in Andover, Mass., is a medical technology company that offers transplant services, including its Organ Care System (OCS), a portable organ preservation system that ...

TMDX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in TransMedics , you are encouraged to obtain additional information ...

TransMedics Group Price Performance Shares of NASDAQ TMDX opened at $65.29 on Friday. The company has a quick ratio of 7.33, a current ratio of 8.20 and a debt-to-equity ratio of 2.42. The ...

NEW YORK, NY / ACCESS Newswire / March 6, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal ...

The paperwhite is the best balance of advanced features and reasonable price of any Kindle, or any other ebook reader. Unlike other Kindles, this one uses a newer type of e-ink, which offers a ...

Check Out Our Latest Analysis on TMDX TransMedics Group Stock Down 9.2 % NASDAQ:TMDX opened at $69.33 on Monday. The company has a market cap of $2.33 billion, a PE ratio of 73.76 and a beta of 2. ...

In my experience, the best PDF editor comes packed with a full suite of features to streamline document creation and management, from clever design tools to security redaction features. My team ...

SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ ...

TMDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the ...

In this article, we are going to take a look at where TransMedics Group, Inc. (NASDAQ:TMDX) stands against other worst performing mid cap stocks to buy according to analysts. Market analysts are ...

TransMedics Group Inc (NASDAQ:TMDX) reported a strong Q4 2024 with total revenue of $121.6 million, representing approximately 50% growth year over year. The company's US revenue grew 11% ...

For the quarter ended December 2024, TransMedics (TMDX) reported revenue of $121.62 million, up 49.8% over the same period last year. EPS came in at $0.19, compared to $0.12 in the year-ago quarter.